Description
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety ofSAR443820in Adult Participants With Amyotrophic Lateral Sclerosis, Followed by an Open-label Extension
Location: CPMC (San Francisco)
Please contact: ClinicalResearch@sutterhealth.org about study Sanofi ACT16970